Pharma’s China crack up

The headlines from Tuesday’s ethiXbase Monitor, a daily email of global corruption and compliance news, tell the story.

Here are the first four items:

China: Glaxo Executive Says Changes in China to Cut Drug Prices
Published on Jul 24, 2013 03:00 am
GlaxoSmithKline Plc (GSK)’s head of emerging markets said after meeting with government officials in Beijing some employees may have broken China’s laws and pledged corporate changes that will deliver cheaper medicines.